Ansell Limited (ANSLY)
USD 74.95
(4.4%)
USD 74.95
(4.4%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 206.3 Million USD | -26.53% |
| 2023 | 280.8 Million USD | -10.67% |
| 2022 | 302.1 Million USD | -27.63% |
| 2021 | 401.6 Million USD | 45.99% |
| 2020 | 276.9 Million USD | 21.3% |
| 2019 | 203.3 Million USD | 1.82% |
| 2018 | 208.5 Million USD | 0.06% |
| 2017 | 226.3 Million USD | -6.21% |
| 2016 | 243.7 Million USD | 13.88% |
| 2015 | 285.9 Million USD | -0.97% |
| 2014 | 126.3 Million USD | 25.22% |
| 2013 | 184.89 Million USD | -7.32% |
| 2012 | 183.63 Million USD | -3.11% |
| 2011 | 164.34 Million USD | 52.19% |
| 2010 | 147.79 Million USD | 6.15% |
| 2009 | 117.81 Million USD | -23.29% |
| 2008 | 149.38 Million USD | 35.31% |
| 2007 | 113.5 Million USD | 16.75% |
| 2006 | 128.53 Million USD | -7.49% |
| 2005 | 105.09 Million USD | 19.2% |
| 2004 | 114.71 Million USD | 7.12% |
| 2003 | 116.97 Million USD | -4.73% |
| 2002 | 86.38 Million USD | 65.98% |
| 2001 | 52.04 Million USD | 54.83% |
| 2000 | 33.61 Million USD | -75.22% |
| 1999 | 135.65 Million USD | 59.56% |
| 1998 | 85.02 Million USD | -43.53% |
| 1997 | 200.78 Million USD | 42.66% |
| 1996 | 133.73 Million USD | -43.32% |
| 1995 | 261.22 Million USD | -38.43% |
| 1994 | 415.32 Million USD | 27.45% |
| 1993 | 353.79 Million USD | -12.17% |
| 1992 | 362.56 Million USD | -2.69% |
| 1991 | 362.04 Million USD | -27.46% |
| 1990 | 499.09 Million USD | 28.51% |
| 1989 | 388.36 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - USD | 1.44% |
| 2024 Q4 | 125.65 Million USD | 84.12% |
| 2024 Q3 | 69.65 Million USD | -10.13% |
| 2024 Q2 | 75.7 Million USD | 50.05% |
| 2024 Q1 | 51.65 Million USD | -66.12% |
| 2023 FY | - USD | -10.67% |
| 2023 Q1 | 57.85 Million USD | -63.15% |
| 2023 Q2 | 126.7 Million USD | 119.01% |
| 2023 Q3 | 69.25 Million USD | -45.34% |
| 2023 Q4 | 151.14 Million USD | 118.26% |
| 2022 FY | - USD | -27.63% |
| 2022 Q4 | 156.99 Million USD | 0.0% |
| 2022 Q2 | 146.3 Million USD | 0.0% |
| 2021 Q4 | 211.47 Million USD | 0.0% |
| 2021 FY | - USD | 45.99% |
| 2021 Q2 | 175.3 Million USD | 0.0% |
| 2020 Q2 | 119.7 Million USD | 0.0% |
| 2020 Q4 | 159.8 Million USD | 0.0% |
| 2020 FY | - USD | 21.3% |
| 2019 Q4 | 134.25 Million USD | 0.0% |
| 2019 FY | - USD | 1.82% |
| 2019 Q2 | 151.48 Million USD | 0.0% |
| 2018 Q2 | 118.28 Million USD | 0.0% |
| 2018 FY | - USD | 0.06% |
| 2018 Q4 | 181.18 Million USD | 0.0% |
| 2017 Q2 | 141.49 Million USD | 0.0% |
| 2017 FY | - USD | -6.21% |
| 2017 Q4 | 138.82 Million USD | 0.0% |
| 2016 Q2 | 161.07 Million USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 FY | - USD | 13.88% |
| 2015 Q4 | 201.26 Million USD | 0.0% |
| 2015 Q2 | 165.7 Million USD | 0.0% |
| 2015 FY | - USD | -0.97% |
| 2014 Q1 | 46.43 Million USD | -60.69% |
| 2014 Q2 | 105.27 Million USD | 126.7% |
| 2014 Q3 | 30.32 Million USD | -71.19% |
| 2014 FY | - USD | 25.22% |
| 2014 Q4 | 149.56 Million USD | 393.2% |
| 2013 Q4 | 118.11 Million USD | 128.03% |
| 2013 FY | - USD | -7.32% |
| 2013 Q1 | 45.51 Million USD | 0.0% |
| 2013 Q2 | 51.79 Million USD | 13.8% |
| 2013 Q3 | 51.8 Million USD | 0.02% |
| 2012 Q2 | 46.85 Million USD | 17.83% |
| 2012 Q4 | - USD | -100.0% |
| 2012 FY | - USD | -3.11% |
| 2012 Q1 | 39.76 Million USD | 0.0% |
| 2012 Q3 | 45.49 Million USD | -2.9% |
| 2011 Q1 | 41.46 Million USD | 0.0% |
| 2011 FY | - USD | 52.19% |
| 2011 Q4 | - USD | -100.0% |
| 2011 Q3 | 42.2 Million USD | 3.95% |
| 2011 Q2 | 40.6 Million USD | -2.08% |
| 2010 FY | - USD | 6.15% |
| 2010 Q4 | - USD | -100.0% |
| 2010 Q3 | 39.37 Million USD | 3.18% |
| 2010 Q1 | 38.69 Million USD | 0.0% |
| 2010 Q2 | 38.15 Million USD | -1.39% |
| 2009 Q4 | - USD | -100.0% |
| 2009 FY | - USD | -23.29% |
| 2009 Q1 | 31.64 Million USD | 0.0% |
| 2009 Q2 | 28.74 Million USD | -9.16% |
| 2009 Q3 | 31.44 Million USD | 9.4% |
| 2008 FY | - USD | 35.31% |
| 2008 Q3 | 37.65 Million USD | 2.02% |
| 2008 Q2 | 36.9 Million USD | 8.73% |
| 2008 Q1 | 33.94 Million USD | 0.0% |
| 2008 Q4 | - USD | -100.0% |
| 2007 Q1 | 31.7 Million USD | 0.0% |
| 2007 Q4 | - USD | -100.0% |
| 2007 Q3 | 31.11 Million USD | 4.45% |
| 2007 Q2 | 29.78 Million USD | -6.04% |
| 2007 FY | - USD | 16.75% |
| 2006 FY | - USD | -7.49% |
| 2006 Q1 | 19.03 Million USD | 0.0% |
| 2006 Q4 | - USD | -100.0% |
| 2006 Q2 | 31.79 Million USD | 67.03% |
| 2006 Q3 | 30.12 Million USD | -5.26% |
| 2005 Q1 | 30.23 Million USD | 0.0% |
| 2005 FY | - USD | 19.2% |
| 2005 Q2 | 19.37 Million USD | -35.91% |
| 2005 Q4 | - USD | -100.0% |
| 2005 Q3 | 19.3 Million USD | -0.39% |
| 2004 FY | - USD | 7.12% |
| 2004 Q2 | 32.09 Million USD | 9.98% |
| 2004 Q1 | 29.18 Million USD | 0.0% |
| 2004 Q4 | - USD | -100.0% |
| 2004 Q3 | 31.8 Million USD | -0.93% |
| 2003 FY | - USD | -4.73% |
| 2003 Q2 | 25.11 Million USD | 191.77% |
| 2003 Q1 | 8.6 Million USD | 0.0% |
| 2003 Q4 | - USD | -100.0% |
| 2003 Q3 | 25.66 Million USD | 2.16% |
| 2002 Q4 | - USD | -100.0% |
| 2002 Q3 | 8.4 Million USD | 4.45% |
| 2002 FY | - USD | 65.98% |
| 2002 Q1 | 41.79 Million USD | 0.0% |
| 2002 Q2 | 8.04 Million USD | -80.75% |
| 2001 Q1 | 12.26 Million USD | 0.0% |
| 2001 FY | - USD | 54.83% |
| 2001 Q4 | - USD | -100.0% |
| 2001 Q3 | 41.62 Million USD | -10.97% |
| 2001 Q2 | 46.75 Million USD | 281.35% |
| 2000 FY | - USD | -75.22% |
| 2000 Q1 | 49.16 Million USD | 0.0% |
| 2000 Q3 | 13.7 Million USD | -5.61% |
| 2000 Q2 | 14.51 Million USD | -70.47% |
| 2000 Q4 | - USD | -100.0% |
| 1999 Q4 | - USD | -100.0% |
| 1999 FY | - USD | 59.56% |
| 1999 Q3 | 47.38 Million USD | 0.27% |
| 1999 Q1 | 33.13 Million USD | 0.0% |
| 1999 Q2 | 47.25 Million USD | 42.61% |
| 1998 Q4 | - USD | -100.0% |
| 1998 FY | - USD | -43.53% |
| 1998 Q3 | 36.66 Million USD | -3.21% |
| 1998 Q1 | 47.09 Million USD | 0.0% |
| 1998 Q2 | 37.88 Million USD | -19.57% |
| 1997 Q4 | - USD | -100.0% |
| 1997 Q3 | 50.87 Million USD | 2.31% |
| 1997 Q1 | 73.3 Million USD | 0.2% |
| 1997 FY | - USD | 42.66% |
| 1997 Q2 | 49.72 Million USD | -32.17% |
| 1996 Q1 | 122.17 Million USD | 5.73% |
| 1996 FY | - USD | -43.32% |
| 1996 Q2 | 69.58 Million USD | -43.05% |
| 1996 Q3 | 72.41 Million USD | 4.06% |
| 1996 Q4 | 73.16 Million USD | 1.03% |
| 1995 Q3 | 118.32 Million USD | -3.37% |
| 1995 Q4 | 115.55 Million USD | -2.34% |
| 1995 FY | - USD | -38.43% |
| 1995 Q1 | 155.37 Million USD | 1.58% |
| 1995 Q2 | 122.45 Million USD | -21.19% |
| 1994 Q1 | 121.13 Million USD | -3.57% |
| 1994 FY | - USD | 27.45% |
| 1994 Q4 | 152.95 Million USD | 3.49% |
| 1994 Q2 | 148.99 Million USD | 23.0% |
| 1994 Q3 | 147.8 Million USD | -0.8% |
| 1993 Q3 | 131.52 Million USD | 3.72% |
| 1993 Q4 | 125.61 Million USD | -4.5% |
| 1993 FY | - USD | -12.17% |
| 1993 Q2 | 126.81 Million USD | 10.45% |
| 1993 Q1 | 114.81 Million USD | -3.88% |
| 1992 Q4 | 119.44 Million USD | -2.8% |
| 1992 FY | - USD | -2.69% |
| 1992 Q1 | 117.49 Million USD | 3.93% |
| 1992 Q2 | 119.9 Million USD | 2.05% |
| 1992 Q3 | 122.89 Million USD | 2.49% |
| 1991 Q3 | 114.18 Million USD | -1.11% |
| 1991 Q4 | 113.05 Million USD | -0.99% |
| 1991 Q2 | 115.46 Million USD | -19.52% |
| 1991 FY | - USD | -29.53% |
| 1991 Q1 | 143.47 Million USD | 4.87% |
| 1990 Q1 | 48.29 Million USD | 2.5% |
| 1990 Q2 | 133.41 Million USD | 176.22% |
| 1990 Q3 | 130.29 Million USD | -2.34% |
| 1990 Q4 | 136.8 Million USD | 5.0% |
| 1990 FY | - USD | 33.52% |
| 1989 Q2 | 54.9 Million USD | 0.0% |
| 1989 FY | - USD | 0.0% |
| 1989 Q4 | 47.12 Million USD | -7.21% |
| 1989 Q3 | 50.78 Million USD | -7.51% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | 21501.436% |
| Ansell Limited | 209.86 Million USD | 1.697% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 42.83 Million USD | -381.562% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | 12795.767% |
| Psykey, Inc. | -1.29 Million USD | 16026.763% |
| ConvaTec Group Plc | 455.5 Million USD | 54.709% |
| ConvaTec Group Plc | 455.5 Million USD | 54.709% |
| Encision Inc. | -544.19 Thousand USD | 38009.205% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 145576.342% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 187764.878% |
| Innovative MedTech Inc. | -7.67 Million USD | 2788.362% |
| LifePoint, Inc. | -14.2 Million USD | 1552.598% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 3434.411% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | 63576.923% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | 95949.169% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | 50939.856% |
| SmileDirectClub, Inc. | -186.13 Million USD | 210.831% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | 53.933% |
| SheerVision, Inc. | -110.53 Thousand USD | 186744.471% |
| United Health Products, Inc. | -2.5 Million USD | 8344.698% |
| Vasamed, Inc. | -4.57 Million USD | 4609.84% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | 9225.347% |
| Yubo International Biotech Limited | -1.17 Million USD | 17617.403% |